Pancreatic cancer is often diagnosed late and can move quickly, so when standard treatment stops working, time and clear information matter. Even so, the next conversation with your oncologist can still cover meaningful ground, from testing that may have been missed to symptom control and pre-approval access pathways.
This guide explains the questions worth bringing to your oncologist, when a second opinion can help, and how the FDA’s pre-approval pathways work, so you and your family can make informed decisions together.
What to ask your oncologist
Questions specific to pancreatic cancer:
- Has my tumor had molecular (genomic) testing, and have I had germline (inherited) genetic testing?
- Could any test results open approved options that we have not yet considered?
- Is my cancer locally advanced or metastatic, and how does that affect what we should discuss next?
- What can we do now to manage pain, digestion, and nutrition, and should I see a palliative care team?
- How quickly do we need to make decisions, and what should we do in parallel?
Questions worth asking for any advanced cancer:
- What are the goals of treatment from here: control, symptom relief, or comfort?
- Are there any approved options we have not yet discussed, including ones used off-label?
- Would you support me getting a second opinion, and who would you recommend?
- Would a pre-approval pathway such as expanded access or Right to Try be worth discussing for me?
- Can we bring in palliative and supportive care now, alongside any other treatment?
